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Lysis of avidin-coated biotinylated sheep red blood cells (RBC) via the classical pathway of homologous (sheep) and heterologous (guinea pig) 
complement has been studied. The mimmal surface density of avidin inducing antibody-dependent lysis vta the classical pathway is smaller than 
that inducing antibody-independent lysis via the alternative pathway. Heterologous lysis via the classical pathway does not depend on the mode 
of avidin attachment: both biotinylation of membrane amino groups and insertion of biotinyl-lipid into the membrane provide the same lysis of 
avidin-coated RBCs by guinea pig serum in the presence of anti-avidin antibody. Avidin-free sheep RBC sensitized with hemolytic anti-RBC 
antibody were lysed by guinea pig, but not by sheep serum. confirming high efficiency of homologous restriction of the complement. However, 
avidin-coated RBCs were lysed by homologous serum in the presence of anti-avidin antibody at low surface density of avidin attached. The 
elimination of the homologous restriction depends on the mode of avidin attachment: biotinylatron of membrane amino groups provides antibody- 
mediated lysis via the classical pathway of homologous complement, while insertion of biotmyl-lipid does not provide lysis. 
Avidm; Complement; Btotinylated erythrocyte; Homologous restriction; Btotm ester; Biotinyl-lipid 
1. INTRODUCTION 
As described previously, avidin attachment to bioti- 
nylated RBCs induces their lysis by homologous com- 
plement activated via the alternative pathway (alterna- 
tive pathway of the complement, APC) [l]. Only avidin 
attachment via amino groups of the RBC membrane 
biotinylated with biotin N-hydroxysuccinimide ster in- 
duces lysis [l-3], while avidin attachment via biotinyl- 
lipid [4] or via tannic acid [5] does not induce lysis. 
Avidin possesses four biotin-binding sites [6]; multiva- 
lent binding of avidin to biotinylated RBC membranes 
seems to be essential for lysis [7]. 
The cell membrane contains proteins inactivating the 
membrane-bound complement: a complement receptor 
type 1 (CRl), a decay accelerating factor (DAF), a fac- 
tor of homologous restriction (HRF) and a membrane 
inhibitor of reactive lysis (MIRL) [g-13]. Some of these 
proteins are clusterized in the cell membrane; such a 
clusterization is important for the inactivation of the 
membrane-bound complement [9]. Avidin might rear- 
range biotinylated membrane proteins (cross-linking, 
destruction of clusters, etc.), leading to their inactiva- 
tion and to the activation of the complement. There are 
two pathways of complement activation: the classical 
Correspondence address: V.R. Muzykantov, Institute of Environ- 
mental Medicine, University of Pennsylvania, Medical Center, One 
John Morgan Building, 36th Street and Hamilton Walk. Philadelphia, 
PA 19104-6068, USA. Fax: (1) (215) 898 0868. 
pathway of the complement (CPC, mediated by Clq 
binding with the antibody) and the alternative pathway 
(APC, mediated by direct binding of C3) [lo]. Mem- 
brane inhibitors regulate both pathways of the comple- 
ment: CR1 and DAF inactivate CPC-convertase (mem- 
brane-bound C4) as well as APC-convertase (mem- 
brane-bound C3), while HRF and MIRL inactivate the 
terminal components of the complement regardless of 
the pathway of complement activation [8,9,1 l-131. In- 
activation of the homologous complement is more effec- 
tive compared with the heterologous one [13]. 
Since avidin attachment induces homologous lysis by 
complement via the APC (i.e. eliminates homologous 
restriction of the complement) [l], we have suggested 
that avidin attachment may also induce lysis of biotinyl- 
ated RBCs by homologous complement via the CPC. 
Here we studied lysis of avidin-coated sheep RBCs by 
homologous and heterologous complement at reduced 
surface density of membrane-bound avidin, which does 
not induce lysis by complement via the APC. We found 
that in the presence of anti-avidin antibodies, these 
RBCs lysed by heterologous and homologous comple- 
ment activated via the CPC. 
2. MATERIALS AND METHODS 
Avidin was purified from hen egg white [14]. Sheep RBCs were 
prepared by defibrinatmg the blood with glass beads. Lyophilized 
guinea pig serum or fresh autologous heep serum was used as a source 
of complement. Rabbit antiserum to avidin was obtained and charac- 
terized as described earlier [7]. 
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Biotinylation of the RBCs and subsequent attachment of avidin 
were performed as described previously [15]. Briefly, 3 ~1 of 0.1 M 
biotin N-hydroxysuccinimide ester and 0.1 ml of 0.1 M sodium tetra- 
borate were added to 10% suspension of RBCs washed with PBS (PBS, 
phosphate-buffered saline, pH 7.4). After a 20-min incubation at 20°C 
cells were washed with PBS (5 x 15 ml). Avidin was added to a 10% 
suspension of biotinylated RBCs and after 2&60 min of incubation 
at 4°C cells were washed with PBS (3 x 15 ml). Avidin was labeled with 
[‘251]-Bolton-Hunter r agent (Amersham) according to the manufac- 
turer’s recommendations. 
A hemolytic assay was performed in microtitration plates as de- 
scribed previously, using standard veronal-buffered saline (VBS) [16]. 
The RBCs examined (50 ~1 of 2% suspension) were added to 50 ~1 of 
complement (2-fold serial dilution in VBS). Plates were incubated at 
37°C for 60 min and the hemolysis degree was measured as absorb- 
ance at 630 nm in an MR-580 Micro Elisa Auto Reader (Dinatech, 
USA). Wells with complement-free VBS and RBCs were used as a 
reference point of 0% hemolysis, while lysis by distilled water served 
as a reference point of 100% hemolysis. For avidin-independent lysis 
via the CPC, sheep RBCs were routinely sensibilized with rabbit he- 
molytic antibody [IO] and lysis by heterologous complement via the 
CPC was performed using lyophilized guinea-pig serum diluted in 
VBS as described earlier [16]. For antibody-mediated lysis of avrdin- 
coated RBCs, these cells were added to the reaction mixture contain- 
ing guinea pig serum (or sheep serum) and heat-inactivated rabbit 
anti-avidin antiserum (final antiserum dilution 1:80). Heat-inactivated 
pooled serum from normal non-immune rabbits added at the same 
dilution (1:80) was used as a control of antibody-mediated lysis. 
Avidin attachment to RBCs via the biotinyl-lipid was performed as 
described earlier [4]. Biotin-phosphatidylethanolamine (biotmyl- 
lipid, biotinyl-PE) was prepared as described [17]. Biotinyl-PE was 
dispersed in PBS at l-2 mg/ml and sonicated under a stream of argon 
gas at 4°C to clarity (5 x 30 s, 50 W, Labline Labsonic System with 
microtip). The lipid dispersion obtained was incubated in a 10% sus- 
pension of the washed RBCs for 1 h at 37°C with gentle rocking. 
Unbound lipid was removed by triple washing with PBS. All subse- 
quent procedures (avidin binding to the RBC, hemolysis, etc.) were 
performed as described above for biotinylated RBC. 
3. RESULTS AND DISCUSSION 
To induce an antibody-mediated activation of the 
complement via the CPC we used a rabbit antiserum to 
avidin. However, since avidin attachment o biotinyl- 
ated RBCs leads to their lysis via the APC even in the 
absence of anti-avidin antibody [l], at the first stage we 
should find conditions allowing lysis via the CPC with- 
out lysis via the APC. For this purpose we reduced the 
surface density of the avidin attached to biotinylated 
sheep RBCs. Attachment of less than 1.5-2.0.10’ avidin 
molecules per RBC does not induce lysis by homolo- 
gous serum in the absence of anti-avidin antibody (Fig. 
1). Therefore, at low surface density of membrane- 
bound avidin we could avoid lysis via the APC. Very 
similar results were obtained using Mg-EgTA-VBS in- 
stead of calcium-containing complete VBS, supporting 
antibody-independent lysis by homologous complement 
activated via the alternative pathway (not shown). 
In the presence of anti-avidin antibody, sheep RBCs 
carrying avidin attached at a low surface density were 
lysed, whereas in the absence of the antibody there was 
no lysis (Fig. 2, pooled serum from normal non-immune 
rabbits was used as a control and shown as closed 
squares in this figure). This indicates antibody-mediated 
activation of the complement via the classical, but not 
via the alternative pathway. As a source of the comple- 
ment in this experiment lyophilized guinea pig serum 
was used, i.e. antibody-induced activation of the 
heterologous complement via the CPC was observed. 
Data shown in Figs. 1 and 2 suggest hat the critical 
surface density of avidin for homologous complement 
activation via the APC is higher than that for heterolo- 
gous complement activation via the CPC (2. lo5 avidin 
molecules per cell vs. 2. lo4 molecules, respectively). 
It should be noted that the antibody-induced lysis of 
avidin-coated RBCs by heterologous complement acti- 
vated via the CPC does not depend on the mode of 
avidin attachment o the RBC. Fig. 2 compares two 
methods of avidin attachment: biotinylation of the 
membrane amino groups with N-hydroxysuccinimide 
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Fig. 1. Lysis of avidin-coated biotinylated sheep RBCs by autologous serum via the alternative pathway of complement (APC). A, dependence 
of lysis on serum dilution. Surface densities of avidin attached per RBC: 0.8.10’ molecules (A); 1.6.10’ molecules(m); 2.1.10’ molecules (0); 3.5. lo5 
molecules (0); and 6.5.10’ molecules (0). B, lysis at serum dilutions: l/4 (0); 1132 (m) and 11128 (A). 
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Fig. 2. Antibody-mediated heterologous lysis of avidin-coated sheep RBCs by guinea pig serum via the classical pathway of complement (CPC). 
Avidin (2.2. lo4 molecules per cell) was attached via biotinylated amino groups (A) or via biotinyl-lipid inserted into the membrane(B). Incubation 
with guinea pig serum was performed in the presence (circles) or in the absence (squares) of heat-inactivated rabbit anti-avidin antiserum. 
biotin ester (part A) and insertion of biotinyl-lipid into 
the membrane (part B). Both methods of avidin attach- 
ment lead to lysis by heterologous complement in the 
presence of anti-avidin antibody (no lysis was observed 
in the absence of antibody). As it was described previ- 
ously, avidin attachment via the biotinyl-lipid (up to 
5 * 10’ avidin molecules per cell) does not in- 
duce lysis via the alternative pathway [4]. Therefore, 
antibody- induced lysis of avidin-coated RBCs by 
heterologous complement via the CPC differs from ho- 
mologous lysis via the APC; heterologous lysis via the 
CPC does not depend on the mode of avidin attachment 
to RBC, while homologous lysis via the APC depends 
on the mode of avidin attachment. 
We compared antibody-induced lysis of sheep RBCs 
by heterologous and homologous complement activated 
via the classical pathway. Fig. 3 shows lysis of avidin- 
free sheep RBCs treated with rabbit hemolytic antibody 
against sheep RBC. Only heterologous serum induced 
lysis, supporting the high efficiency of the homologous 
restriction of complement. However, avidin-coated bi- 
otinylated RBCs were lysed by homologous comple- 
ment in the presence of anti-avidin antibody, while in 
the absence of anti-avidin antibody no lysis was ob- 
served (Fig. 4, pooled serum from normal non-immune 
rabbits was used as a control and shown as closed 
squares). This result supports the suggestion that avidin 
attachment o the biotinylated RBC membrane elimi- 
nates homologous restriction of both classical (CPC) 
and alternative (APC) pathways. 
As mentioned above, the mode of avidin attachment 
is essential for the activation of homologous comple- 
ment via the APC [4], but has no influence on the acti- 
vation of heterologous complement via the CPC (Fig. 
2). In contrast to heterologous complement, lysis by 
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homologous complement via the CPC depends on the 
mode of avidin attachment. Fig. 4 compares avidin at- 
tachment via biotinylated amino groups (1.6.10’ avidin 
molecules per cell) and via biotinyl-lipid inserted into 
the membrane (3.8. lo5 avidin molecules per cell). In 
contrast with avidin attached via biotinylated amino 
groups, avidin attached via biotinyl-lipid does not in- 
duce lysis by homologous complement regardless of the 
presence of anti-avidin antibody. 
Summarizing the results of this and previous work, 
we can make the following conclusion. 
First, avidin attached to biotinylated RBCs at high 
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Fig. 3. Antibody-mediated lysis of sheep RBCs by homologous (sheep 
serum, n ) or heterologous (guinea pig serum, l ) complement activated 
via the classical pathway. Sheep RBCs were sensitized with rabbit 
hemolytic antibody by standard procedure. 
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Fig. 4. Antibody-mediated lysis of avidin-coated sheep RBCs by homologous complement via the classical pathway. A, avidin attached to 
biotinylated amino groups of the membrane (1.6.10’ molecules per cell); B, avidin attached to biotinyl-lipid inserted into the membrane (3.8. lo5 
molecules per cell). Incubation in fresh sheep serum in the presence (0) or in the absence (w) of anti-avidin serum. 
surface density eliminates homologous restriction of the 
complement and induces lysis via the APC [l]. This 
effect of avidin depends on the mode of its attachment. 
Only attachment o biotinylated amino groups is ef- 
fetive, while attachment via biotinyl-lipid [4] or via tan- 
nit acid [5] is non-effective. Lysis by homologous com- 
plement via the APC does not occur at attachment of 
less than 2.10’ avidin molecules per sheep RBC. 
Second, avidin attached to RBCs might serve as a 
‘cellular antigen’ and provide lysis of RBCs by heterol- 
ogous complement activated by the anti-avidin anti- 
body. This effect of avidin does not depend on the mode 
of its attachment: both biotin ester-anchored and bioti- 
nyl-lipid-anchored avidin induces lysis (Fig. 2), as well 
as tannin-anchored avidin [5]. Efficiency of antibody- 
mediated lysis of avidin-coated RBCs by heterologous 
complement via the CPC is very high and occurs at a 
low surface density of avidin attached (2. lo4 molecules 
per sheep RBC). 
Third, avidin attached to the biotinylated membrane 
at low surface density induces membrane rearrange- 
ment and elimination of the homologous restriction of 
the complement, while no lysis via the APC occurs. 
Elimination of homologous restriction at a low surface 
density of avidin may be revealed using anti-avidin anti- 
body-mediated lysis by homologous complement acti- 
vated via the CPC. Lysis by homologous complement 
via the CPC, as well as lysis via the APC, depends on 
the mode of avidin attachment. Attachment of avidin to 
biotinylated amino groups provides lysis, while attach- 
ment to biotinyl-lipids inserted into the membrane does 
not provide lysis. Efficiency of lysis of avidin-coated 
RBCs by homologous complement via the CPC is 
higher than via the APC. 
Therefore, avidin induces considerable alterations in 
the RBC membrane leading to the elimination of the 
homologous restriction of the complement. This is of 
interest, since applications of the avidin-biotin complex 
for the investigation of circulating RBCs in vivo was 
recently suggested [18-201. Bearing in mind the avidin- 
induced alterations in the RBC membrane, we should 
carefully study the biocompatibility of avidin-modified 
RBC and the safety of avidin applications in vivo [21]. 
In addition, the avidin-induced elimination of the ho- 
mologous restriction seems to be an interesting model 
for the investigation of the mechanisms of cell lysis by 
complement, as well as mechanisms of cellular defence 
against homologous complement. 
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